<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | George Barnett | Activity</title>
	<link>https://www.catswannabecats.com/members/cannonlimit64/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/cannonlimit64/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for George Barnett.</description>
	<lastBuildDate>Fri, 19 Jun 2026 15:42:02 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">ff3a3891705b6069d9d967d8cd6b920e</guid>
				<title>George Barnett posted an update: Distal bypass (DB) is the optimal treatment for patients [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/25888/</link>
				<pubDate>Mon, 09 Jun 2025 12:10:24 -0400</pubDate>

									<content:encoded><![CDATA[<p>Distal bypass (DB) is the optimal treatment for patients with critical limb ischemia (CLI). However, effectiveness of DB for patients with intermittent claudication (IC) remains uncertain. This study aimed to analyze long-term results of DB for IC patients (IC-DB) compared with those of DB for CLI patients (CLI-DB).</p>
<p> Patients undergoing DB&hellip;<span class="activity-read-more" id="activity-read-more-25888"><a href="https://www.catswannabecats.com/activity/p/25888/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c87b81fa13e55da685c56a8cc1d60fff</guid>
				<title>George Barnett posted an update: Ferroelectric materials may be used as effective [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/24523/</link>
				<pubDate>Sun, 08 Jun 2025 12:53:56 -0400</pubDate>

									<content:encoded><![CDATA[<p>Ferroelectric materials may be used as effective photoelectrocatalysts for water splitting due to enhanced charge carrier separation driven by their spontaneous polarization induced internal electric field. Compared to other ferroelectric materials, BiFeO3 exhibits a high catalytic efficiency due to its comparatively smaller bandgap, which enables&hellip;<span class="activity-read-more" id="activity-read-more-24523"><a href="https://www.catswannabecats.com/activity/p/24523/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0bdf43a0e85922fa547d3a2d06698916</guid>
				<title>George Barnett posted an update: Taken together, our established cell lines could serve as a [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/21067/</link>
				<pubDate>Fri, 06 Jun 2025 12:38:25 -0400</pubDate>

									<content:encoded><![CDATA[<p>Taken together, our established cell lines could serve as a useful in vitro tool for pulp regeneration therapy, and can contribute to reproducibility and ease of cell handling, thereby saving time and costs associated with safety and quality control tests.In the era of smartphones, route-planning and navigation is supported by freely and globally&hellip;<span class="activity-read-more" id="activity-read-more-21067"><a href="https://www.catswannabecats.com/activity/p/21067/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4e03ece13be95b9c69180c01be0c3da2</guid>
				<title>George Barnett posted an update: Two were OOT over the full dose range one elected not to [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20253/</link>
				<pubDate>Thu, 05 Jun 2025 12:25:00 -0400</pubDate>

									<content:encoded><![CDATA[<p>Two were OOT over the full dose range one elected not to remeasure; the other also had positional discrepancy greater than 1&nbsp;mm and repeat measurement with a new plan was in tolerance. The original OOT was attributed to inappropriate MLC constraints. All centres delivered planned target-cord dose gradient within 1&nbsp;mm. CONCLUSION Credentialing&hellip;<span class="activity-read-more" id="activity-read-more-20253"><a href="https://www.catswannabecats.com/activity/p/20253/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">bdec26282387aa1ab867b9a09c861a89</guid>
				<title>George Barnett posted an update: OBJECTIVE The aim of this study was to explore the effect of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/8428/</link>
				<pubDate>Sat, 31 May 2025 21:09:44 -0400</pubDate>

									<content:encoded><![CDATA[<p>OBJECTIVE The aim of this study was to explore the effect of neurotrophin-3 (NT-3) on the repair of spinal cord injury (SCI) through the mitogen-activated protein kinase (MAPK) signaling pathway. MATERIALS AND METHODS The rat model of SCI was first successfully established using the impactor (SCI group). Meanwhile, control group and NT-3 treatment&hellip;<span class="activity-read-more" id="activity-read-more-8428"><a href="https://www.catswannabecats.com/activity/p/8428/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">49512e16fb6d41e878479ccc30e30e69</guid>
				<title>George Barnett became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/8249/</link>
				<pubDate>Sat, 31 May 2025 20:54:30 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>